Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Resources Guokang Pharmaceuticals
Rockville, Maryland, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
CASI Pharmaceuticals (previously known as China Resources Guokang Pharmaceuticals) is an oncology‑focused company that in‑licenses US/EU‑approved hematology‑oncology drugs for commercialization in China and develops additional oncology assets; its current portfolio includes FDA‑approved products such as melphalan hydrochloride for injection and other hematology‑oncology therapies that are in commercial use in China while earlier‑stage assets are in various clinical phases.[2][4][8][9][10][11][6]
- Therapeutic areas
- Oncology
- Modalities
- Small moleculeBiologicMonoclonal antibodyCell therapy
- Industry
- Biotech
02
Partnerships
Spectrum Pharmaceuticals (in‑licensed three FDA‑approved hematology‑oncology drugs for China rights, including melphalan hydrochloride for injection)[2][4][10]China Resources Guokang (historic relationship implied by former name and distribution activities in China)[6]Juventas Cell Therapy (co‑marketing partnership for CD19 CAR‑T product CNCT19 in China)[6][11]
Beyond the preview
Go deeper on China Resources Guokang Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on China Resources Guokang Pharmaceuticals.